Cited by 97Amyotrophic Lateral Sclerosis ResearchCellular transport and secretionAlzheimer's disease research and treatments

Endocytosis regulates TDP-43 toxicity and turnover

Open access
Liu, Guangbo, Coyne, Alyssa N., Pei, Fen, Vaughan, Spencer, Chaung, Matthew, Zarnescu, Daniela C., Buchan, J. Ross·2017·Nature Communications

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron degenerative disease. ALS-affected motor neurons exhibit aberrant localization of a nuclear RNA binding protein, TDP-43, into cytoplasmic aggregates, which contributes to pathology via unclear mechanisms. Here, we demonstrate that TDP-43 turnover and toxicity depend in part upon the endocytosis pathway. TDP-43 inhibits endocytosis, and co-localizes strongly with endocytic proteins, including in ALS patient tissue. Impairing endocytosis increases TDP-43 toxicity, aggregation, and protein levels, whereas enhancing endocytosis reverses these phenotypes. Locomotor dysfunction in a TDP-43 ALS fly model is also exacerbated and suppressed by impairment and enhancement of endocytic function, respectively. Thus, endocytosis dysfunction may be an underlying cause of ALS pathology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-02017-x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dynamics of endocytosis modulate TDP-43 expression in a TDP-43 amyotrophic lateral sclerosis fly model.

    “In addition, dynamics of endocytosis modulate TDP-43 expression in a TDP-43 ALS fly model [175].”

    From Insights of Endocytosis Signaling in Health and Disease (2023) · cites this paper as [175]

    The Results section, “Endocytosis affects TDP-43-induced ALS phenotypes in flies” (page unavailable), shows that altering endocytic proteins changes locomotor dysfunction and neurodegeneration in a TDP-43 fly model. It does not show that endocytosis modulates TDP-43 expression levels in those flies; the reported fly outcomes are TDP-43-induced phenotypes. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 62

  1. [1]Boillée S Vande Velde C Cleveland DW ALS: a disease of motor neurons and their nonneuronal neighbors Neuron 2006 52 39 59 10.1016/j.neuron.2006.09.018 17015226 · DOI
  2. [2]Neumann M Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 2006 314 130 133 10.1126/science.1134108 17023659 · DOI · Paper page
  3. [3]Lee EB Lee VM Trojanowski JQ Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration Nat. Rev. Neurosci. 2011 13 38 50 22127299 PMC3285250
  4. [4]Parker SJ Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates Neurochem. Int. 2012 60 415 424 10.1016/j.neuint.2012.01.019 22306778 · DOI
  5. [5]Buchan JR Parker R Eukaryotic stress granules: the ins and outs of translation Mol. Cell 2009 36 932 941 10.1016/j.molcel.2009.11.020 20064460 PMC2813218 · DOI
  6. [6]Renton AE Chiò A Traynor BJ State of play in amyotrophic lateral sclerosis genetics Nat. Neurosci. 2014 17 17 23 10.1038/nn.3584 24369373 PMC4544832 · DOI
  7. [7]Aulas A Vande Velde C Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS? Front. Cell. Neurosci. 2015 9 423 10.3389/fncel.2015.00423 26557057 PMC4615823 · DOI
  8. [8]Kim HJ Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models Nat. Genet. 2014 46 152 160 10.1038/ng.2853 24336168 PMC3934366 · DOI
  9. [9]Becker LA Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice Nature 2017 544 367 371 10.1038/nature22038 28405022 PMC5642042 · DOI · Paper page
  10. [10]Scotter EL Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species J. Cell Sci. 2014 127 1263 1278 10.1242/jcs.140087 24424030 PMC3953816 · DOI
  11. [11]Wang X Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system Neurosci. Lett. 2010 469 112 116 10.1016/j.neulet.2009.11.055 19944744 · DOI · Paper page
  12. [12]Barmada SJ Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models Nat. Chem. Biol. 2014 10 677 685 10.1038/nchembio.1563 24974230 PMC4106236 · DOI · Paper page
  13. [13]Wang IF Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43 Proc. Natl Acad. Sci. USA 2012 109 15024 15029 10.1073/pnas.1206362109 22932872 PMC3443184 · DOI · Paper page
  14. [14]Buchan JR Kolaitis RM Taylor JP Parker R Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function Cell 2013 153 1461 1474 10.1016/j.cell.2013.05.037 23791177 PMC3760148 · DOI · Paper page
  15. [15]Guo H Autophagy supports genomic stability by degrading retrotransposon RNA Nat. Commun. 2014 5 5276 10.1038/ncomms6276 25366815 · DOI
  16. [16]Khurana V Lindquist S Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker’s yeast? Nat. Rev. Neurosci. 2010 11 436 449 10.1038/nrn2809 20424620 · DOI
  17. [17]Elden AC Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS Nature 2010 466 1069 1075 10.1038/nature09320 20740007 PMC2965417 · DOI
  18. [19]Li F Autophagic recycling plays a central role in maize nitrogen remobilization Plant Cell 2015 5 1389 1408 10.1105/tpc.15.00158 PMC4456646 25944100 · DOI · Paper page
  19. [20]Armakola M Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models Nat. Genet. 2012 44 1302 1309 10.1038/ng.2434 23104007 PMC3510335 · DOI
  20. [21]Feyder S De Craene JO Bär S Bertazzi D Friant S Membrane trafficking in the yeast Saccharomyces cerevisiae Model Int. J. Mol. Sci. 2015 67 1509 1525 10.3390/ijms16011509 PMC4307317 25584613 · DOI
  21. [22]Jean S Kiger AA Classes of phosphoinositide 3-kinases at a glance J. Cell Sci. 2014 127 923 928 10.1242/jcs.093773 24587488 PMC3937771 · DOI
  22. [23]Itakura E Kishi C Inoue K Mizushima N Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG Mol. Biol. Cell 2008 19 5360 5372 10.1091/mbc.E08-01-0080 18843052 PMC2592660 · DOI · Paper page
  23. [24]Liang C Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG Nat. Cell Biol. 2006 8 688 699 10.1038/ncb1426 16799551 · DOI
  24. [26]Yu A Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition Proc. Natl Acad. Sci. USA 2014 111 E1481 E1490 10.1073/pnas.1321811111 24706768 PMC3992642 · DOI
  25. [27]Tuo S Nakashima K Pringle JR Role of endocytosis in localization and maintenance of the spatial markers for bud-site selection in yeast PLoS ONE 2013 8 e72123 10.1371/journal.pone.0072123 24039741 PMC3764181 · DOI
  26. [28]Hutagalung AH Novick PJ Role of Rab GTPases in membrane traffic and cell physiology Physiol. Rev. 2011 91 119 149 10.1152/physrev.00059.2009 21248164 PMC3710122 · DOI
  27. [29]Wiederkehr A Meier K D. Riezman H Identification and characterization of Saccharomyces cerevisiae mutants defective in fluid-phase endocytosis Yeast 2001 18 759 773 10.1002/yea.726 11378903 · DOI
  28. [30]Henry KR Scd5p and clathrin function are important for cortical actin organization, endocytosis, and localization of sla2p in yeast Mol. Biol. Cell 2002 13 2607 2625 10.1091/mbc.E02-01-0012 12181333 PMC117929 · DOI
  29. [31]D’Souza-Schorey C Chavrier P ARF proteins: roles in membrane traffic and beyond Nat. Rev. Mol. Cell Biol. 2006 7 347 358 10.1038/nrm1910 16633337 · DOI
  30. [32]Balderhaar HJ Kleine Ungermann C CORVET and HOPS tethering complexes - coordinators of endosome and lysosome fusion J. Cell Sci. 2013 126 1307 1316 10.1242/jcs.107805 23645161 · DOI
  31. [33]Schmidt O Teis D The ESCRT machinery Curr. Biol. 2012 22 R116 R120 10.1016/j.cub.2012.01.028 22361144 PMC3314914 · DOI
  32. [34]Babst M Wendland B Estepa EJ Emr SD The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function EMBO J. 1998 17 2982 2993 10.1093/emboj/17.11.2982 9606181 PMC1170638 · DOI
  33. [35]Schwenk BM TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons EMBO J. 2016 35 2350 2370 10.15252/embj.201694221 27621269 PMC5090220 · DOI
  34. [37]Zhang YJ Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity Proc. Natl Acad. Sci. USA 2009 106 7607 7612 10.1073/pnas.0900688106 19383787 PMC2671323 · DOI
  35. [38]Bucci C The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway Cell 1992 70 715 728 10.1016/0092-8674(92)90306-W 1516130 · DOI
  36. [39]Grbovic OM Rab5-stimulated up-regulation of the endocytic pathway increases intracellular βCTFs levels and Aβ production J. Biol. Chem. 2003 278 31261 31268 10.1074/jbc.M304122200 12761223 · DOI
  37. [40]Ravikumar B Imarisio S Sarkar S O’Kane CJ Rubinsztein DC Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease J. Cell Sci. 2008 121 1649 1660 10.1242/jcs.025726 18430781 PMC2635563 · DOI
  38. [41]Macia E Dynasore, a cell-permeable inhibitor of dynamin Dev. Cell 2006 10 839 850 10.1016/j.devcel.2006.04.002 16740485 · DOI
  39. [42]Hung SY Huang WP Liou HC Fu WM LC3 overexpression reduces Aβ neurotoxicity through increasing α7nAchR expression and autophagic activity in neurons and mice Neuropharmacology 2015 93 243 251 10.1016/j.neuropharm.2015.02.003 25686800 · DOI
  40. [43]Ganley IG Wong PM Gammoh N Jiang X Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest Mol. Cell 2011 42 731 743 10.1016/j.molcel.2011.04.024 21700220 PMC3124681 · DOI
  41. [44]Estes PS Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS Hum. Mol. Genet. 2011 20 2308 2321 10.1093/hmg/ddr124 21441568 PMC3098735 · DOI
  42. [45]Wucherpfennig T Wilsch-Bräuninger M González-Gaitán M Role of Drosophila Rab5 during endosomal trafficking at the synapse and evoked neurotransmitter release J. Cell Biol. 2003 161 609 624 10.1083/jcb.200211087 12743108 PMC2172938 · DOI
  43. [46]Simmonsen A Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila Autophagy 2008 4 176 184 10.4161/auto.5269 18059160 · DOI · Paper page
  44. [47]Chow CY Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS Am. J. Hum. Genet. 2009 84 85 88 10.1016/j.ajhg.2008.12.010 19118816 PMC2668033 · DOI · Paper page
  45. [48]Rudge SA Anderson DM Emr SD Vacuole size control: regulation of PtdIns(3,5)P2 levels by the vacuole-associated Vac14-Fig4 complex, a PtdIns(3,5)P2-specific phosphatase Mol. Biol. Cell 2004 15 24 36 10.1091/mbc.E03-05-0297 14528018 PMC307524 · DOI
  46. [49]Hadano S A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 Nat. Genet. 2001 29 166 173 10.1038/ng1001-166 11586298 · DOI
  47. [52]Hadano S Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking PLoS ONE 2010 5 e9805 10.1371/journal.pone.0009805 20339559 PMC2842444 · DOI
  48. [53]Deshpande M Role of BMP receptor traffic in synaptic growth defects in an ALS model Mol. Biol. Cell 2016 27 2898 2910 10.1091/mbc.E16-07-0519 27535427 PMC5042577 · DOI
  49. [54]Levine TP Daniels RD Gatta AT Wong LH Hayes MJ The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs Bioinformatics 2013 29 499 503 10.1093/bioinformatics/bts725 23329412 PMC3570213 · DOI · Paper page
  50. [57]Sellier C Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death EMBO J. 2016 35 1276 1297 10.15252/embj.201593350 27103069 PMC4910533 · DOI · Paper page
  51. [59]Iguchi Y Exosome secretion is a key pathway for clearance of pathological TDP-43 Brain 2016 139 3187 3201 10.1093/brain/aww237 27679482 PMC5840881 · DOI · Paper page
  52. [60]Lim L Wei Y Lu Y Song J ALS-causing mutations significantly perturb the self-assembly and interaction with nucleic acid of the intrinsically disordered prion-like domain of TDP-43 PLoS Biol. 2016 14 1 35 10.1371/journal.pbio.1002338 PMC4703307 26735904 · DOI
  53. [61]Liu GC Delineating the membrane-disrupting and seeding properties of the TDP-43 amyloidogenic core Chem. Commun. 2013 49 11212 11214 10.1039/c3cc46762g 24154814 · DOI
  54. [62]Coyne AN Post-transcriptional inhibition of Hsc70-4/HSPA8 expression leads to synaptic vesicle cycling defects in multiple models of ALS Cell Rep. 2017 21 110 125 10.1016/j.celrep.2017.09.028 28978466 PMC5679478 · DOI
  55. [63]Urushitani M Sato T Bamba H Hisa Y Tooyama I Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43 J. Neurosci. Res. 2010 88 784 797 19798749
  56. [64]Clague MJ Liu H Urbé S Governance of endocytic trafficking and signaling by reversible ubiquitylation Dev. Cell 2012 23 457 467 10.1016/j.devcel.2012.08.011 22975321 · DOI
  57. [65]Kim SH Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1 J. Biol. Chem. 2009 284 8083 8092 10.1074/jbc.M808064200 19112176 PMC2658102 · DOI
  58. [66]Buchan JR Nissan T Parker R Analyzing P-bodies and stress granules in Saccharomyces cerevisiae Mehods Enzymol. 2010 470 619 640 10.1016/S0076-6879(10)70025-2 20946828 · DOI
  59. [67]Schindelin J Fiji: an open-source platform for biological-image analysis Nat. Methods 2012 9 676 682 10.1038/nmeth.2019 22743772 PMC3855844 · DOI · Paper page
  60. [68]de Araújo, M. E. G., Lamberti, G. & Huber, L. A. Purification of early and late endosomes. Cold Spring Harb. Protoc.10.1101/pdb.top074443 (2015). 26631131 · DOI
  61. [69]Li X Donowitz M Fractionation of subcellular membrane vesicles of epithelial and non-epithelial cells by OptiPrep™ density gradient ultracentrifugation Methods Mol. Biol. 2014 174 85 99 10.1007/978-1-4939-0944-5_6 24947376 · DOI
  62. [70]Cherry S Charcot-Marie-Tooth 2B mutations in rab7 cause dosage dependent neurodegeneration due to partial loss of function Elife 2013 10 e01064 PMC3857549 24327558

Cited by

Sorted by citations

Authors
Liu, G., Coyne, A. N., Pei, F., Vaughan, S., Chaung, M., Zarnescu, D. C., & Buchan, J. R.
Affiliations
University of Arizona (US)
Corresponding author
Buchan, J. Ross
Venue
Nature Communications
Published
2017-12-12
Volume
8
Issue
1
Pages
2092-2092
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2775661933
Cited by
97
References
8
Citations by year
2026: 4 · 2025: 15 · 2024: 11 · 2023: 9 · 2022: 10 · 2021: 18 · 2020: 14 · 2019: 7 · 2018: 9
FWCI
5.72
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UA Campus Repository (The University of Arizona) (acceptedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • ALS Association
  • University of Arizona
  • National Institutes of Health (RO1 NS091299, NS091299)
  • National Institute of General Medical Sciences (R01GM114564)
  • National Institute of Neurological Disorders and Stroke (R01NS091299)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
TDP-43, amyotrophic lateral sclerosis, endocytosis, protein turnover, protein aggregation, motor neuron degeneration, RNA-binding proteins, endocytic proteins, locomotor dysfunction, Drosophila model
MeSH terms
Amyotrophic Lateral Sclerosis, Animals, Cell Nucleus, Disease Models, Animal, DNA-Binding Proteins, Drosophila, Endocytosis, Frontal Lobe, Humans, Locomotion, Motor Neurons, RNA-Binding Proteins, HEK293 Cells, Protein Aggregation, Pathological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review